• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.72% Nasdaq Down0.92%

    ImmunoCellular Therapeutics, Ltd. (IMUC)

    -NYSE MKT
    0.25 Down 0.01(3.69%) 3:00PM EDT - Nasdaq Real Time Price
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2015Dec 31, 2014Dec 31, 2013
    Total Revenue -   -   -  
    Cost of Revenue -   -   -  
    Gross Profit -   -   -  
    Operating Expenses
    Research Development10,897  5,969  5,340  
    Selling General and Administrative4,617  3,889  4,121  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (15,513) (9,859) (9,460)
    Income from Continuing Operations
    Total Other Income/Expenses Net2,945  544  660  
    Earnings Before Interest And Taxes(12,568)(9,315)(8,801)
    Interest Expense223  63   -  
    Income Before Tax(12,791)(9,378)(8,801)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(12,791)(9,378)(8,801)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (12,791) (9,378) (8,801)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (12,791) (9,378) (8,801)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.